Clinical trial
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
NCT00494013 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00494013 |
|---|---|
| Title | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) |
| Official title | Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus |
| Acronym | IOOY |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | Insulin Lispro Protamine Suspension, Detemir |
| Enrollment | 442 |
| Start date | Aug 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jun 29, 2007 |
| Last update posted | Nov 11, 2009 |
| Countries | Argentina, Hungary, India, Mexico, Poland, South Korea, Spain, Taiwan, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: